<VariationArchive VariationID="1344893" VariationName="NM_000942.5(PPIB):c.434_435del (p.Lys145fs)" VariationType="Deletion" Accession="VCV001344893" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1336665" VariationID="1344893">
      <GeneList>
        <Gene Symbol="PPIB" FullName="peptidylprolyl isomerase B" GeneID="5479" HGNC_ID="HGNC:9255" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q22.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="64155817" stop="64163022" display_start="64155817" display_stop="64163022" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="64448013" stop="64455353" display_start="64448013" display_stop="64455353" Strand="-" />
          </Location>
          <OMIM>123841</OMIM>
        </Gene>
        <Gene Symbol="SNX22" FullName="sorting nexin 22" GeneID="79856" HGNC_ID="HGNC:16315" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q22.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="64151731" stop="64157481" display_start="64151731" display_stop="64157481" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="64443915" stop="64449679" display_start="64443915" display_stop="64449679" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000942.5(PPIB):c.434_435del (p.Lys145fs)</Name>
      <CanonicalSPDI>NC_000015.10:64156817:TTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q22.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="64449017" stop="64449018" display_start="64449017" display_stop="64449018" variantLength="2" positionVCF="64449016" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="64156818" stop="64156819" display_start="64156818" display_stop="64156819" variantLength="2" positionVCF="64156817" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K145fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.64156819_64156820del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.64156819_64156820del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000942.5" sequenceAccession="NM_000942" sequenceVersion="5" change="c.434_435del" MANESelect="true">
            <Expression>NM_000942.5:c.434_435del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000933.1" sequenceAccession="NP_000933" sequenceVersion="1" change="p.Lys145fs">
            <Expression>NP_000933.1:p.Lys145fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024798.3" sequenceAccession="NM_024798" sequenceVersion="3" change="c.*2311_*2312del" MANESelect="true">
            <Expression>NM_024798.3:c.*2311_*2312del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_073534.2" sequenceAccession="NR_073534" sequenceVersion="2" change="n.2985_2986del">
            <Expression>NR_073534.2:n.2985_2986del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.64449018_64449019del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.64449018_64449019del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012979.1" sequenceAccession="NG_012979" sequenceVersion="1" change="g.11337_11338del">
            <Expression>NG_012979.1:g.11337_11338del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033071.1" sequenceAccession="NG_033071" sequenceVersion="1" change="g.10103_10104del">
            <Expression>NG_033071.1:g.10103_10104del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_10" sequenceAccession="LRG_10">
            <Expression>LRG_10:g.11337_11338del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_10t1" sequenceAccession="LRG_10t1">
            <Expression>LRG_10t1:c.434_435del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1211592084" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000942.5(PPIB):c.434_435del (p.Lys145fs) AND Osteogenesis imperfecta type 9" Accession="RCV001849895" Version="3">
        <ClassifiedConditionList TraitSetID="5557">
          <ClassifiedCondition DB="MedGen" ID="C1850169">Osteogenesis imperfecta type 9</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-05" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000942.5(PPIB):c.434_435del (p.Lys145fs) AND not provided" Accession="RCV003120724" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-10" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19781681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29620724</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-11">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5557" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3329" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type 9</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+9/5464" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009805" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oi type IX</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI 9</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta sillence type II/III without abnormality of type I collagen</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI9</ElementValue>
                <XRef Type="MIM" ID="259440" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10619" />
                <XRef ID="10619" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C1850169" DB="MedGen" />
              <XRef ID="MONDO:0009805" DB="MONDO" />
              <XRef Type="MIM" ID="259440" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4124532" SubmissionDate="2022-04-01" DateLastUpdated="2022-04-02" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NVNT1216|MedGen:C1850169" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002107159" DateUpdated="2022-04-02" DateCreated="2022-03-28" Type="SCV" Version="2" SubmitterName="DASA" OrgID="508087" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.434_435delAA;p.(Lys145fs) is a null frameshift variant (NMD) in the PPIB gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevant exon to the transcript - PVS1_strong. This variant is not present in population databases (rs1211592084- gnomAD; ABraOM no frequency - http://abraom.ib.usp.br.) - PM2. In summary, the currently available evidence indicates that the variant is likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPIB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000942.4:exon 4</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="1211592084" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000942.4:c.434_435del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1850169" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11164938</SubmissionName>
          <SubmissionName>SUB11265037</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7067540" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="9715948|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003787305" DateUpdated="2024-02-20" DateCreated="2023-02-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19781681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29620724</ID>
          </Citation>
          <Comment>This variant is present in population databases (no rsID available, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Lys145Argfs*47) in the PPIB gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 72 amino acid(s) of the PPIB protein. This variant has not been reported in the literature in individuals affected with PPIB-related conditions. ClinVar contains an entry for this variant (Variation ID: 1344893). This variant disrupts a region of the PPIB protein in which other variant(s) (p.Q151*) have been determined to be pathogenic (PMID: 19781681, 29620724). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPIB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.64449017_64449018del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7067540" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4124532" TraitType="Disease" MappingType="XRef" MappingValue="C1850169" MappingRef="MedGen">
        <MedGen CUI="C1850169" Name="Osteogenesis imperfecta type 9" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

